BY KRISTEN BUCKLES
The Greene County Insurance Committee heard monthly reports at a meeting on Wednesday but did not take action because a quorum of the committee members was not present.
The committee, comprised of several county commissioners, the county mayor, department heads and insurance officials, was hindered because of the vacation absence of County Attorney Roger Woolsey.
In his capacity as county attorney, Woolsey's presence is state-mandated for the committee's regular closed session about upcoming claims.
Mayor Alan Broyles said he would have canceled the meeting altogether but for the planned presence of a representative from Georgia-based TransformHealthRx.
Shannon Milton, the company's chief financial and chief operating officer, updated the committee on the operation of the county health clinic.
Milton said that 303 patients have utilized the clinic to approximately 70 percent capacity.
He recommended that the county not expand clinic hours at this time until the number of appointments increases.
Cost to the county for operating the clinic since January has been $115,000, he added.
TransformHealthRx estimated that the same services would have cost the county $542,000 if billed to their insurance plan, for an estimated savings of $427,000.
In other reports, Jim Jordan, of Health Insurance Services, informed the committee that the 2012-2013 year closed with a total of $3.99 million in claims, which is still below the $4.1 million from 2010-2011.
However, he noted that there are also $500,000 in fixed costs and $200,000 for the clinic, putting the county at a total cost of $4.7 million for its insurance program.
Jordan said that the county's target spending for employee health insurance and benefits is $4.6 million annually.
Recent increased costs for employee premiums and deductibles for the 2013-2014 fiscal year should reduce claims, he added.
The committee also learned that UnitedHealthcare, which provides the county's reinsurance, will put the county's prescription plan under their company, OptumRx.
This action should cause minimal changes to employees' plans and pharmacy choices, according to the information presented.